MMJ Group Holdings is a Medical Cannabis company, which aims to commercialise Medical Grade Cannabis (MGC) and high potential cannabis based therapeutics products to the rapidly growing international market with regulated medical cannabis laws. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors.
Previously MMJ Phytotech, the company sold its Phytotech Therapeutics arm in November 2018.